Goldenwell Biotech (GWLL) Return on Equity (2020 - 2025)

Goldenwell Biotech has reported Return on Equity for 6 years, with the latest figure at 0.0% in Q3 2025.

• For the quarter ending Q3 2025, Return on Equity rose 11.0% year-over-year to 0.0%; the trailing twelve-month figure through Sep 2025 stood at 0.0% (up 11.0% YoY), and the FY2024 full-year result was 0.07%, down 6.0% from the prior year.
• Return on Equity for Q3 2025 stood at 0.0%, down from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.03% in Q4 2024, with the low at 0.11% in Q3 2024.
• Historically, Return on Equity has averaged 0.02% across 5 years, with a median of 0.0% in 2022.
• Annual changes were most pronounced in 2023 — Return on Equity fell 8 bps — and 2025, when it climbed 11 bps.
• Goldenwell Biotech's Return on Equity stood at 0.0% in 2021, then plunged by 1102 bps to 0.04% in 2022, then surged by 73 bps to 0.01% in 2023, then jumped by 310 bps to 0.03% in 2024, then tumbled by 109 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.01% (Q1 2025), per Business Quant data.